Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These Healthcare Names: Gossamer Bio (GOSS) and Biogen (BIIB)

Tipranks - Tipranks - Fri Apr 3, 4:02AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Gossamer Bio (GOSS) and Biogen (BIIB).

End of Quarter Sale - 50% Off TipRanks

Gossamer Bio (GOSS)

In a report released today, Eliana Merle from Barclays maintained a Sell rating on Gossamer Bio, with a price target of $0.30. The company’s shares closed last Wednesday at $0.37.

According to TipRanks.com, Merle is a 3-star analyst with an average return of 3.1% and a 39.7% success rate. Merle covers the Healthcare sector, focusing on stocks such as Sagimet Biosciences, Inc. Class A, Ultragenyx Pharmaceutical, and 4D Molecular Therapeutics. ;'>

Currently, the analyst consensus on Gossamer Bio is a Hold with an average price target of $4.40, implying a 1206.4% upside from current levels. In a report issued on March 22, TipRanks – OpenAI also downgraded the stock to Sell with a $0.40 price target.

See Insiders’ Hot Stocks on TipRanks >>

Biogen (BIIB)

In a report released today, Emily Field from Barclays maintained a Hold rating on Biogen, with a price target of $185.00. The company’s shares closed last Wednesday at $183.78.

According to TipRanks.com, Field is a 2-star analyst with an average return of 0.7% and a 41.6% success rate. Field covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, GlaxoSmithKline, and Merck & Company. ;'>

Biogen has an analyst consensus of Moderate Buy, with a price target consensus of $208.43, representing a 13.8% upside. In a report released yesterday, TipRanks – xAI also downgraded the stock to Hold with a $195.00 price target.

Read More on GOSS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).